Medications
Who should not take a GLP-1? Contraindications and cautions
July 23, 2026 · 2 min read
The short answer
Some people should not take GLP-1 receptor agonists. The clearest contraindications are a personal or family history of medullary thyroid cancer or the genetic syndrome MEN2, and a known serious allergy to the drug. Pregnancy and breastfeeding are also reasons to avoid them.
Others can often take them but need caution and closer monitoring: a history of pancreatitis, gallbladder disease, severe gastrointestinal conditions, type 1 diabetes, eating disorders, and use with insulin or a sulfonylurea. This is always an individual, clinician-led decision.
Who should not take a GLP-1 at all
GLP-1 receptor agonists (Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda) are effective, but they are not for everyone. Some situations are firm reasons to avoid them:
- A personal or family history of medullary thyroid cancer, or the genetic syndrome multiple endocrine neoplasia type 2 (MEN2). These drugs carry a boxed warning based on thyroid C-cell tumors seen in rodent studies, and they are contraindicated in these people.
- A known serious allergy (hypersensitivity) to the specific medication or its ingredients.
- Pregnancy and breastfeeding. They are not recommended during pregnancy or while nursing, because of limited safety data and the fact that weight loss is not appropriate in pregnancy.
Who needs caution and closer monitoring
Many people can take a GLP-1 but need extra care and a case-by-case discussion:
- A history of pancreatitis. Because pancreatitis is a recognized, if uncommon, risk, past episodes prompt caution.
- Gallbladder disease. These drugs carry a small increased risk of gallbladder problems, so existing disease is weighed carefully. Our gallbladder post covers this.
- Severe gastrointestinal disease, such as gastroparesis (a stomach that already empties too slowly) or serious reflux, since these drugs slow the stomach further.
- Type 1 diabetes. GLP-1s are not a substitute for insulin and are generally not used for weight loss in type 1 diabetes without specialist input.
- A history of eating disorders, where appetite-suppressing medication needs careful, supported handling.
- Use with insulin or a sulfonylurea, which raises the risk of low blood sugar and usually means those doses are adjusted.
Why this has to be individual
Whether a GLP-1 is right for you depends on your full history, not a checklist alone, which is exactly why a prescriber assesses you before starting. Tell them about your medical and family history, all your medications, and any past reactions. Our how to qualify post covers the eligibility side, and the Ozempic safety post puts the risks in context. This article is general information, not medical advice, and is not a substitute for a clinician's assessment.
Questions people ask
Who should not take GLP-1 medications?
People with a personal or family history of medullary thyroid cancer or MEN2, a known serious allergy to the drug, and those who are pregnant or breastfeeding should not take them. Others, like people with a history of pancreatitis, need caution and a case-by-case decision.
Can you take a GLP-1 if you've had pancreatitis?
It requires caution and an individual decision with your clinician, because pancreatitis is a recognized, if uncommon, risk with these drugs. A history of pancreatitis is a reason for careful weighing rather than an automatic yes or no.
Are GLP-1 drugs safe with other diabetes medications?
They can be used with many, but combining them with insulin or a sulfonylurea raises the risk of low blood sugar, so those doses are usually adjusted. Type 1 diabetes needs specialist input, since GLP-1s do not replace insulin. Your prescriber manages the combination.
Why are GLP-1 drugs not recommended in pregnancy?
There is limited human safety data, animal studies raised concerns, and weight loss is not appropriate during pregnancy, when adequate nutrition matters. They are also not recommended while breastfeeding. Planning around pregnancy is a decision to make with your clinician.
References
- 1.Ozempic and Wegovy (semaglutide) prescribing information: dosing, adverse reactions, and warnings. View label on DailyMed ↗
- 2.Mounjaro and Zepbound (tirzepatide) prescribing information: dosing, adverse reactions, and warnings. View label on DailyMed ↗
- 3.Contraindications and warnings for GLP-1 receptor agonists (thyroid C-cell, pancreatitis) reviews. Find on PubMed ↗
This article is general education, not medical advice. DoseLog is a tracking and reflection tool. Decisions about your medication, dose, and symptoms belong with a licensed clinician.
Keep reading